|
ZNF845 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.2885000000048E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24950000002233E-06 |
| Normal-vs-Stage2 |
3.417200E-03 |
| Normal-vs-Stage3 |
1.819510E-02 |
| Normal-vs-Stage4 |
4.551100E-04 |
| Stage1-vs-Stage2 |
7.346800E-01 |
| Stage1-vs-Stage3 |
4.776200E-01 |
| Stage1-vs-Stage4 |
4.701400E-01 |
| Stage2-vs-Stage3 |
8.174600E-01 |
| Stage2-vs-Stage4 |
3.777400E-01 |
| Stage3-vs-Stage4 |
3.387000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64450000001071E-06 |
| Normal-vs-AfricanAmerican |
2.034500E-04 |
| Normal-vs-Asian |
7.110300E-02 |
| Caucasian-vs-AfricanAmerican |
9.208200E-01 |
| Caucasian-vs-Asian |
7.439000E-01 |
| AfricanAmerican-vs-Asian |
7.532200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08780000007691E-07 |
| Normal-vs-Female |
1.735990E-01 |
| Male-vs-Female |
8.609600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.623700E-04 |
| Normal-vs-Extreme_Weight |
1.04880000018071E-07 |
| Normal-vs-Obese |
6.884500E-03 |
| Normal-vs-Extreme_Obese |
4.017900E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.043800E-01 |
| Normal_Weight-vs-Obese |
1.673050E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.517200E-01 |
| Extreme_Weight-vs-Obese |
8.941500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.010600E-01 |
| Obese-vs-Extreme_Obese |
1.534590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.163000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.763300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.8228999998946E-07 |
| Normal-vs-Age(81-100Yrs) |
1.83928999999416E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.341200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.499800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.576200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.434400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.250400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.453000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.49519999995229E-06 |
| Normal-VS-Type2 PRCC |
1.39040000002311E-06 |
| Normal-VS-KIRP CIMP |
9.792000E-01 |
| Normal-VS-Unclassified PRCC |
2.185600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.415600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.830000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.436400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.785960E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.781900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.919800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67150000507377E-08 |
| Normal-vs-N1 |
4.908200E-01 |
| Normal-vs-N2 |
7.044200E-04 |
| N0-vs-N1 |
7.216000E-03 |
| N0-vs-N2 |
4.650400E-01 |
| N1-vs-N2 |
1.056570E-01 |
|
|
